- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
---|---|---|---|---|---|---|
Director, Patient Advocacy Europe | Basel (City) | Switzerland | Corporate Affairs | CTS | Communications & Public Affairs | Jul 17, 2024 |
Service Delivery Manager | Dublin (Country President Office (CPO)) | Ireland | International | Innovative Medicines | Communications & Public Affairs | Jul 16, 2024 |
Senior Manager, Communications - Global Functions & Leadership | Basel (City) | Switzerland | Corporate Affairs | CTS | Communications & Public Affairs | Jul 16, 2024 |
Director, Other Radiosensitive Tumors & Rare Disease Communications | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 16, 2024 |
Associate Director, R&D Portfolio and Engagement - Communications | Cambridge (Massachusetts) | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 15, 2024 |
Associate Director, Marketing Copywriter | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 12, 2024 |
Associate Director, US Enterprise & Leader Communications | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 12, 2024 |
Director, US Reputation & Corporate Storytelling | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 10, 2024 |
Manager, US Policy & Issues Communications | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 10, 2024 |
Director, US Policy & Issues Communications | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 10, 2024 |
Manager, US Reputation & Corporate Storytelling | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 10, 2024 |
Director, US Strategy & Executive Communications | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 10, 2024 |
Associate Director, US Content & Channel Strategy | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 10, 2024 |
Public Affairs Manager (m/f/d) | Berlin West (Non-Sales Force) (Novartis Pharma GmbH) | Germany | International | Innovative Medicines | Communications & Public Affairs | Jul 09, 2024 |
Director Research & Analytics | Basel (City) | Switzerland | Corporate Affairs | CTS | Communications & Public Affairs | Jul 08, 2024 |
Director, Research & Analytics-Corporate Affairs | East Hanover (New Jersey) | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 08, 2024 |
Comms & Patient Engagement Manager | Amsterdam | Netherlands | Corporate Affairs | CTS | Communications & Public Affairs | Jul 04, 2024 |
Head of Public Affairs - Norway | Oslo | Norway | Corporate Affairs | Innovative Medicines | Communications & Public Affairs | Jul 03, 2024 |
Director, Neuroscience, US Patient Advocacy | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 02, 2024 |
Director, Breast Cancer and Hematology, US Patient Advocacy | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 02, 2024 |
Director, Immunology, US Patient Advocacy | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 02, 2024 |
Director, RLT and Solid Tumors, US Patient Advocacy | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jul 02, 2024 |
Manager, R&D Communications and Engagement | Cambridge (USA) | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jun 20, 2024 |
Manager, Post Production & Video Services | Hyderabad (Office) | India | Corporate Affairs | CTS | Communications & Public Affairs | Jun 17, 2024 |
Associate Director, Paid Social | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jun 14, 2024 |
Manager, US Immunology Communications | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jun 13, 2024 |
Manager, US People & Culture | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jun 13, 2024 |
Manager, US Channel Operations & Publishing | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jun 12, 2024 |
Associate Director, Region Policy Communications & Media Relations | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jun 10, 2024 |
Director of Policy Communications, Advocacy and Media Relations | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jun 07, 2024 |
Senior Manager – Graphic Design | Hyderabad (Office) | India | Corporate Affairs | CTS | Communications & Public Affairs | Jun 06, 2024 |
State Government Affairs & Partnerships Manager | New South Wales (NSW) | Australia | International | Innovative Medicines | Communications & Public Affairs | May 19, 2024 |
State Government Affairs & Partnerships Manager | Western Australia (WA) | Australia | International | Innovative Medicines | Communications & Public Affairs | May 19, 2024 |
Executive Director, Public Affairs LaCan Region | East Hanover | USA | Corporate Affairs | Corporate | Communications & Public Affairs | May 09, 2024 |
Director, Public Affairs | Shanghai (Shanghai) | China | People & Organization | Innovative Medicines | Communications & Public Affairs | May 06, 2024 |
Executive Director, US Patient Advocacy | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | May 02, 2024 |
Executive Director, US Corporate Communication | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | May 02, 2024 |
Patient Engagement Lead | İstanbul Kavacık | Turkey | Corporate Affairs | CTS | Communications & Public Affairs | Apr 17, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى